Troglitazone and rosiglitazone belong to thiazolidinediones, which are syntheticPPAR-gamma agonists and act as insulin sensitizers to treat type 2 diabetes.However, PPAR-gamma has been considered to be a regulator of inflammation andischemic responses in recent years. Here, PPARG is linked to type 2 diabetes mellitus.